Correlation Between 4D Molecular and CEL SCI
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and CEL SCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and CEL SCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and CEL SCI Corp, you can compare the effects of market volatilities on 4D Molecular and CEL SCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of CEL SCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and CEL SCI.
Diversification Opportunities for 4D Molecular and CEL SCI
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between FDMT and CEL is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and CEL SCI Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CEL SCI Corp and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with CEL SCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CEL SCI Corp has no effect on the direction of 4D Molecular i.e., 4D Molecular and CEL SCI go up and down completely randomly.
Pair Corralation between 4D Molecular and CEL SCI
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to generate 0.66 times more return on investment than CEL SCI. However, 4D Molecular Therapeutics is 1.52 times less risky than CEL SCI. It trades about -0.03 of its potential returns per unit of risk. CEL SCI Corp is currently generating about -0.29 per unit of risk. If you would invest 820.00 in 4D Molecular Therapeutics on August 30, 2024 and sell it today you would lose (33.00) from holding 4D Molecular Therapeutics or give up 4.02% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.65% |
| Values | Daily Returns |
4D Molecular Therapeutics vs. CEL SCI Corp
Performance |
| Timeline |
| 4D Molecular Therapeutics |
| CEL SCI Corp |
4D Molecular and CEL SCI Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 4D Molecular and CEL SCI
The main advantage of trading using opposite 4D Molecular and CEL SCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, CEL SCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEL SCI will offset losses from the drop in CEL SCI's long position.| 4D Molecular vs. Revolution Medicines | 4D Molecular vs. Black Diamond Therapeutics | 4D Molecular vs. Passage Bio | 4D Molecular vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges |